Literature DB >> 10477714

Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.

S Ogilvy1, D Metcalf, L Gibson, M L Bath, A W Harris, J M Adams.   

Abstract

To develop a method for targeting expression of genes to the full hematopoietic system, we have used transgenic mice to explore the transcriptional regulation of the vav gene, which is expressed throughout this compartment but rarely outside it. Previously, we showed that a cluster of elements surrounding its promoter could drive hematopoietic-specific expression of a bacterial lacZ reporter gene, but the expression was confined to lymphocytes and was sporadically silenced. Those limitations are ascribed here to the prokaryotic reporter gene. With a human CD4 (hCD4) cell surface reporter, the vav promoter elements drove expression efficiently and stably in virtually all nucleated cells of adult hematopoietic tissues but not notably in nonhematopoietic cell types. In multiple lines, hCD4 appeared on most, if not all, B and T lymphocytes, granulocytes, monocytes, megakaryocytes, eosinophils, and nucleated erythroid cells. Moreover, high levels appeared on both lineage-committed progenitors and the more primitive preprogenitors. In the fetus, expression was evident in erythroid cells of the definitive but not the primitive type. These results indicate that a prokaryotic sequence can inactivate a transcription unit and that the vav promoter region constitutes a potent transgenic vector for the entire definitive hematopoietic compartment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477714

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  83 in total

1.  Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.

Authors:  Sarah H Beachy; Masahiro Onozawa; Yang Jo Chung; Chris Slape; Sven Bilke; Princy Francis; Marbin Pineda; Robert L Walker; Paul Meltzer; Peter D Aplan
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

2.  Cutting Edge: Lymphomyeloid-Primed Progenitor Cell Fates Are Controlled by the Transcription Factor Tal1.

Authors:  Renée F de Pooter; Sheila Dias; Munmun Chowdhury; Elisabeth T Bartom; Michael K Okoreeh; Mikael Sigvardsson; Barbara L Kee
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

3.  The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.

Authors:  S Ogilvy; R Ferreira; S G Piltz; J M Bowen; B Göttgens; A R Green
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

4.  Hematopoietic progenitors from early murine fetal liver possess hepatic differentiation potential.

Authors:  Satish Khurana; Asok Mukhopadhyay
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

5.  Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo.

Authors:  M Mortensen; D J P Ferguson; M Edelmann; B Kessler; K J Morten; M Komatsu; A K Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

6.  NF-kappaB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms.

Authors:  Ashish Banerjee; Raelene Grumont; Raffi Gugasyan; Christine White; Andreas Strasser; Steve Gerondakis
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

7.  Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.

Authors:  Sarah H Beachy; Masahiro Onozawa; Deborah Silverman; Yang Jo Chung; Mariela Martinez Rivera; Peter D Aplan
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

8.  KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice.

Authors:  Yue Wei; Hong Zheng; Naran Bao; Shan Jiang; Carlos E Bueso-Ramos; Joseph Khoury; Caleb Class; Yue Lu; Kevin Lin; Hui Yang; Irene Ganan-Gomez; Daniel T Starczynowski; Kim-Anh Do; Simona Colla; Guillermo Garcia-Manero
Journal:  Blood Adv       Date:  2018-10-09

9.  NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.

Authors:  Ying-Wei Lin; Christopher Slape; Zhenhua Zhang; Peter D Aplan
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

10.  MYC levels govern hematopoietic tumor type and latency in transgenic mice.

Authors:  Darrin P Smith; Mary L Bath; Donald Metcalf; Alan W Harris; Suzanne Cory
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.